Which medication would be a common choice for long-term asthma management?

Corticosteroids are commonly chosen for long-term asthma management due to their anti-inflammatory properties. They effectively reduce airway inflammation, which is a significant factor in asthma exacerbations and persistent symptoms. By decreasing inflammation, corticosteroids help improve lung function, reduce the frequency of asthma attacks, and enhance overall control of the condition.

While long-acting bronchodilators also play a role in long-term asthma management, they primarily work by relaxing the muscles around the airways to maintain open passageways for airflow. They do not address the underlying inflammation as effectively as corticosteroids. Leukotriene modifiers also assist in management but are generally not as potent in controlling inflammation compared to corticosteroids. Short-acting bronchodilators are used for quick relief during sudden asthma symptoms and are not suitable for long-term management, making corticosteroids the optimal choice in this context.